About Us
IT IT
IT
2017/08
2018/02
2018/06
2018/10
2020/04
2020/07
2020/12
2021/06
2022/01
2022/04
TXP Medical
NSER OP
NEXT Stage ER
SIP AI
COVID-19 CRISIS
COVID
Series A 2.5
NSER mobile
NHK BS
Series B
Sonoo
Tomohiro
Slide 7
Slide 7 text
TXP Medical
Business
01
TXP Medical
Next Challenge
02
TXP Medical
Work & Culture
03
Mission
00
Recruit
04
Contents
Slide 8
Slide 8 text
TXP Medical
Business
01
Slide 9
Slide 9 text
Business Overview
TXP Medical
Main Target
2
Slide 10
Slide 10 text
TXP Solution 01
TXP Medical
NSER mobile
Slide 11
Slide 11 text
TXP Solution 01
TXP Medical
Solution
OCR
NEXT Stage ER
Problem
75%
※ 24 3
TXP Medical
64%
2011 2021
Slide 12
Slide 12 text
TXP Solution 02
TXP Medical
NEXT Stage ER
Slide 13
Slide 13 text
TXP Solution 02
TXP Medical
Problem
55%
Solution
Slide 14
Slide 14 text
Results
NHK BS JHeC2022 100
74 2022
11 1
28
22
30
Slide 15
Slide 15 text
Effects of Introduction
NEXT Stage ER
42%
46% 50%
28%
7%
5%
17%
5%
30-60
Slide 16
Slide 16 text
Increase in Users
NSER
66%
109
2021
Slide 17
Slide 17 text
TXP Medical
Next Challenge
02
Slide 18
Slide 18 text
Next Challenge
TXP Medical
01
04
02
03
NSER Mobile
NEXT Stage ER NEXT Stage ICU
NEXT Stage Clinical Trials
Slide 19
Slide 19 text
Next Challenge 02
NEXTStage Oncology
Slide 20
Slide 20 text
•
•
•
•
•
•
• MR
•
•
Next Challenge 03
TXP Medical
TXP
Slide 21
Slide 21 text
Next Challenge 03
NEXT Stage Clinical Trials
NEXT Stage Clinical Trials
Action
NEXT Stage ER
Problem
24 365
NEXT Stage Clinical Trials
Slide 22
Slide 22 text
Future
Action
Problem
Next Challenge 04
NSER mobile NEXT Stage ER NEXT Stage ICU
Slide 23
Slide 23 text
TXP Medical
Work & Culture
03
TXP Medical
Slide 24
Slide 24 text
TXP Value
Factful thinking
Clinically Good, Socially Good
All for one, One for all
TXP TXP
Slide 25
Slide 25 text
Member
MR
20
30
40
5
36
16
8
23
3
17
1
8
7
36
53
CRO
IT
TXP Medical
2
40
13
1
50
1
Slide 26
Slide 26 text
Work Style & Benefit
Work Style
•
11:00~15:00
• 2
• 10
※10
• 1
•
•
• 50
( 1
Benefit
•
IT
•
•
•
PC
Office